EGFR

The Evolving Approach to Management of Stage IV EGFRm NSCLC

Charu Aggarwal, MD, MPH
Integrating NORTHSTAR/COMPEL Into Clinical Practice: A Tumor Board Focused on Duration of Osimertinib Therapy

Zofia Piotrowska, MD, MHS; Charu Aggarwal, MD, MPH
2nd Line Management of EGFRm NSCLC

Charu Aggarwal, MD, MPH; Balazs Halmos, MD
The Evolving Roles of Neoadjuvant and Adjuvant Therapy in EGFRm NSCLC

Tina Cascone, MD, PhD
Early Stage NSCLC – EGFR Mutant NSCLC

Charu Aggarwal, MD, MPH
Advances in The Management of Early-Stage EGFRm NSCLC

Charu Aggarwal, MD, MPH
Multidisciplinary Lung Cancer Tumor Board: Management of Surgically Resected Early-Stage EGFRm NSCLC

Charu Aggarwal, MD, MPH; Tina Cascone, MD, PhD
Multidisciplinary Lung Cancer Tumor Board: Management of Early Stage EGFRm NSCLC

Charu Aggarwal, MD, MPH; Brendon Stiles, MD
Molecular Testing and the Implications for 1L Therapy in Stage IV EGFRm NSCLC

Charu Aggarwal, MD, MPH
Advances in the Management of Stage III NSCLC –Impact of the LAURA Clinical Trial

Charu Aggarwal, MD, MPH
Five Year Update on ADAURA Clinical Trial of Tagrisso in EGFR Early Stage NSCLC

Charu Aggarwal, MD, MPH